Cardiac repolarization abnormalities and increased sympathetic activity in scleroderma

Journal of the National Medical Association

Volumn 99, Issue 3, 2007, Pages 232-237

  Ciftci, Orcun ^a,b   Onat, Ahmet Mesut ^a,d   Yavuz, Bunyamin ^a,d   Akdogan, Ali ^a,c   Aytemir, Kudret ^a,b   Tokgozoglu, Lale ^a,b   Sahiner, Levent ^a,b   Deniz, Ali ^a,b   Ureten, Kemal ^a,d   Kizilca, Guler ^a,e   Calguneri, Meral ^a,c   Oto, Ali ^a,b  

^a Hacettepe University ^*

^b HACETTEPE UNIVERSITY   (Turkey)

^c GAZIANTEP UNIVERSITY   (Turkey)

^d Kecioren Hospital Ankara   (Turkey)

^e SSK Etlik Hospital   (Turkey)

Author keywords

Dermatology; Heart; QT dynamicity; Scleroderma

Indexed keywords

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM FUNCTION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIFFUSE SCLERODERMA; DISEASE PREDISPOSITION; FEMALE; HEART RATE VARIABILITY; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; HEMODYNAMICS; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; QT INTERVAL; RR INTERVAL; SCLERODERMA; SYMPATHETIC TONE; TRANSTHORACIC ECHOCARDIOGRAPHY;

ARRHYTHMIA; CASE-CONTROL STUDIES; FEMALE; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SCLERODERMA, SYSTEMIC; SYMPATHETIC NERVOUS SYSTEM;

EID: 33947169986     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Mitchell H, Bolster MB, Le Roy EC. Scleroderma and related conditions. In: Advances in Rheumatology. Med Clin North Am. 1997;81:129-149.
2. Follansby WP. The cardiovascular manifestations of systemic sclerosis. Curr Prob Cardiol. 1986;11:243-249.
3. Pumprla J, Howorka K, Groves D, et al. Functional assessment of heart rate variability: physiological basis and practical applications. Int J Cardiol. 2002;84:1-14.
4. Pathak A, Curnier D, Fourcade J, et al. QT dynamicity: a prognostic factor for sudden death in chronic heart failure. Eur J Heart Fail. 2005;7:269-275.
5. Zareba W. QT-RR Slope: dynamics of repolarization in the risk stratification. J Cardiovasc Electrophysiol. 2003;14:234-235.
6. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (Scleroderma). Arthritis Rheum. 1980;23:581-590.
7. Clements P, Lachenbruch P, Siebold J, et al. Inter- and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumafol. 1995;22(7):1281-1285.
8. Furst DE. Rational therapy in the treatment of systemic sclerosis. Curr Opin Rheumatol. 2000;12:540-548.
9. Task force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996;93:1043-1065.
10. Sgreccia A, Morelli S, Ferrante L, et al. QT interval and QT dispersion in systemic sclerosis (scleroderma). J Intern Med. 1998;243:127-132.
11. Wranicz JK, Zielinska M, Cygankiewicz I, et al. Early cardiovascular involvement in patients with systemic sclerosis (SSc). Med Sci Monit. 2002; 8(2):CR78-CR82.
12. Fauchier L, Babuty D, Poret P, et al. Effect of verapamil on QT interval Dynamicity. Am J Cardiol. 1999;83:807-808.
13. Ellidokuz E, Kaya D. The effect of metoclopropamide on QT dynamicity: double blind, placebo-controlled, cross-over study in healthy male volunteers. Aliment Pharmacol Ther. 2003;18:151-155.
14. Bonnemeier H, Ortak J, Tölg R, et al. Carvedilol versus metoprolol in patients undergoing direct percutaneous coronary interventions for myocardial infarction: effects on QT dynamicity. Pace. 2005;28:S217-S221.
15. Milliez P, Leenhardt A, Maisonblanche P, et al. Usefulness of ventricular repolarization dynamicity in predicting arrhythmic deaths in patients with ischemic cardiomyopathy (from the European Myocardial Infarct Amiodarone Trial). Am J Cardiol. 2005;95:821-826.
16. Tavernier R, Jordaens L, Haerynck F, et al. Changes in the QT interval and its adaptation to rate, assessed with continuous electrocardiographic recordings in patients with ventricular fibrillation, assessment compared to normal individuals without arrhytmias. Eur Heart J. 1997;18:994-999.
17. Bonnemeier H, Wiegand UKH, Bode F, et al. Impact of infarct-related artery flow on QT dynamicity in patients undergoing direct percutaneous coronary intervention for acute myocardial infarction. Circulation. 2003; 108:2979-2986.
18. Schwartz PJ, Locati EH, Moss AJ, et al. Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome-a worldwide report. Circulation. 1991;84:503-511.
19. Suarez-Almazor ME, Bruera E, Russel AS. Rheumatic cardiovascular autonomic function in patients with systemic sclerosis. Ann Rheum Dis. 1988;47:672-674.
20. Dessein PH, Joffe BI, Metz RM, et al. Autonomic dysfunction in systemic sclerosis: sympathetic overactivity and instability. Am J Med. 1992;93:143-149.
21. Hermosillo AG, Ortiz R, Dabague J, et al. Autonomic dysfunction in Diffuse Scleroderma vs CREST: an assessment by computerized heart variability. J Rheumatol. 1994;21:1849-1854.
22. Ferri C, Emdin M, Giuggioli D, et al. Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis. Br J Rheum. 1997;36:669-676.
23. Morelli S, Piccirillo G, Fimognari F, et al. Twenty-four hour heart period variability in systemic sclerosis. J Rheumatol. 1996;23(4):643-645.
24. Follansbee WP, Miller TR, Curtiss EI, et al. A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). J Rheumatol. 1990;17:656-662.
25. D'Angelo WA, Fries JF, Masi AT, et al. Pathologic observation in systemic sclerosis [scleroderma): a study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med. 1969;46:428-440.
26. James TN. Subitaneis moritbus: coronary arteries and conduction system in scleroderma heart disease. Circulation. 1974;50:844-856.
27. Sackner MA, Argun N, Kimbel P. The pathophysiology of scleroderma involving the heart and respiratory system. Ann Intern Med. 1964;60:611-630.
28. Bulkley BH, Ridolfi RL, Salyer WR, et al. Myocardial lesions of progressive systemic sclerosis: a cause of cardiac dysfunction. Circulation. 1976;53:483-490.